Streetbeat News

Regulatory

HUMA

Humacyte has released its third quarter 2024 financial results and provided a business update. The FDA is currently reviewing their acellular tissue engineered vessel (ATEV™) BLA for the treatment of vascular trauma.

Portfolio Pulse from

November 08, 2024 | 1:15 pm

DNKEY

Danske Bank A/S reported transactions by persons with managerial responsibilities, as required by the Danish FSA and Nasdaq Copenhagen.

Portfolio Pulse from

November 08, 2024 | 1:00 pm

NVAX

Levi & Korsinsky has initiated an investigation into Novavax, Inc. for potential violations of federal securities laws. This follows the FDA's clinical hold on Novavax's combination influenza and Covid-19 shot and its stand-alone influenza vaccine.

Portfolio Pulse from

November 08, 2024 | 12:45 pm

CAE

Levi & Korsinsky has initiated an investigation into CAE Inc. for potential violations of federal securities laws. This may affect investors who purchased CAE shares on the NYSE.

Portfolio Pulse from

November 08, 2024 | 12:45 pm

RVNC

Levi & Korsinsky has initiated an investigation into Revance Therapeutics, Inc. (NASDAQ:RVNC) for potential securities fraud. The investigation follows Revance's disclosure of alleged breaches in its distribution agreement with Teoxane SA.

Portfolio Pulse from

November 08, 2024 | 12:45 pm

HUMA

Levi & Korsinsky has initiated an investigation into Humacyte, Inc. for potential securities fraud violations following FDA findings of significant quality control issues at its North Carolina facility.

Portfolio Pulse from

November 08, 2024 | 12:45 pm

DZSI

Levi & Korsinsky has initiated an investigation into DZS Inc. for potential violations of federal securities laws, focusing on errors in financial statements and issues with internal controls.

Portfolio Pulse from

November 08, 2024 | 12:45 pm

TMSNY

Levi & Korsinsky has initiated an investigation into Temenos AG for potential violations of federal securities laws, following a report by Hindenburg Research alleging major accounting irregularities and failed products.

Portfolio Pulse from

November 08, 2024 | 12:45 pm

EXPI

Levi & Korsinsky has initiated an investigation into eXp World Holdings, Inc. (NASDAQ:EXPI) for potential violations of federal securities laws. The investigation focuses on allegations of sexual misconduct by top agents and executives, and the company's failure to address these issues.

Portfolio Pulse from

November 08, 2024 | 12:45 pm